Skin and pigmentation

Melanotan II

Editorial audit: October 15, 2026 · draft; scientific, medical and translation review pending

NOT A RECOMMENDATION.Each amount is attributed to the source identified for that entry: regulatory product labeling, human research, or community and practice sources. These source categories have different evidentiary roles. They are not medical advice, not a protocol, not a recommended or safe dose, and not evidence that it works. Do not use them to start, change or stop any treatment. Talk to a qualified healthcare professional.

01What is reported

Community sources describe pigmentation and tanning routines, sometimes with deliberate ultraviolet exposure. Unregulated nasal products are another route of exposure.

NOT A RECOMMENDATION.Each amount is attributed to the source identified for that entry: regulatory product labeling, human research, or community and practice sources. These source categories have different evidentiary roles. They are not medical advice, not a protocol, not a recommended or safe dose, and not evidence that it works. Do not use them to start, change or stop any treatment. Talk to a qualified healthcare professional.

02Proposed rationale

Pigmentation signaling is not equivalent to protection from ultraviolet injury. Afamelanotide and melanotan II must remain distinct.

03What the research shows

An afamelanotide product has a narrow approved context. TGA testing of a small set of melanotan sprays found content inconsistent with labels.

04Limits and unknowns

Do not transfer afamelanotide approval to melanotan II or interpret increased pigmentation as sunscreen protection. A targeted testing sample is not a market-wide prevalence estimate.

NOT A RECOMMENDATION.Each amount is attributed to the source identified for that entry: regulatory product labeling, human research, or community and practice sources. These source categories have different evidentiary roles. They are not medical advice, not a protocol, not a recommended or safe dose, and not evidence that it works. Do not use them to start, change or stop any treatment. Talk to a qualified healthcare professional.

05Questions to ask about the product

Is the substance and route actually verified, and does the label match measured content?

NOT A RECOMMENDATION.Each amount is attributed to the source identified for that entry: regulatory product labeling, human research, or community and practice sources. These source categories have different evidentiary roles. They are not medical advice, not a protocol, not a recommended or safe dose, and not evidence that it works. Do not use them to start, change or stop any treatment. Talk to a qualified healthcare professional.

06Open research question

Can an evidence map identify where tanning claims substitute pigmentation for a clinically meaningful protection outcome?

Primary and regulatory references

  1. 1.
  2. 2.
  3. 3.
A community-based bilingual scientific education initiative for healthcare professionals and the general public across the Americas.Currently self-funded; no current sponsors. Formal governance and legal documentation pending.info@peptideamericas.org · Planned contact address — not active yet; please do not send messages.